{
    "id": 26268,
    "fullName": "NF2 Y153fs",
    "impact": "frameshift",
    "proteinEffect": "loss of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "NF2 Y153fs results in a change in the amino acid sequence of the Nf2 protein beginning at aa 153 of 595, likely resulting in premature truncation of the functional protein (UniProt.org). Y153fs has not been biochemically characterized however, due to the effects of truncation mutations downstream of Y153 (PMID: 19910496, PMID: 31257748), is predicted to lead to a loss of Nf2 protein function.",
            "references": [
                {
                    "id": 17214,
                    "pubMedId": 31257748,
                    "title": "Expression of NF2 Modulates the Progression of BRAFV600E Mutated Thyroid Cancer Cells.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31257748"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 17549,
                    "pubMedId": 19910496,
                    "title": "Tumor-suppression functions of merlin are independent of its role as an organizer of the actin cytoskeleton in Schwann cells.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/19910496"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 4771,
        "geneSymbol": "NF2",
        "terms": [
            "NF2",
            "ACN",
            "BANF",
            "SCH"
        ]
    },
    "variant": "Y153fs",
    "createDate": "04/06/2017",
    "updateDate": "01/15/2020",
    "referenceTranscriptCoordinates": {
        "id": 88868,
        "transcript": "NM_000268",
        "gDna": "chr22:g.29654667dupA",
        "cDna": "c.458dupA",
        "protein": "p.Y153fs*1",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 10456,
            "approvalStatus": "Case Reports/Case Series",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical case study, the combination of Afinitor (everolimus) and Taxol (paclitaxel) resulted in a partial response lasting over 13 months in a metastatic urothelial carcinoma patient harboring NF2 Y153fs*1, as well as ATM V2119fs*8, an ATR splice site mutation, and TP53 R280K, who had progressed on platinum-based chemotherapy and single agent Taxotere (docetaxel) therapy (PMID: 25630452).",
            "molecularProfile": {
                "id": 27471,
                "profileName": "ATM V2119fs ATR mut NF2 Y153fs TP53 R280K"
            },
            "therapy": {
                "id": 5505,
                "therapyName": "Everolimus + Paclitaxel",
                "synonyms": null
            },
            "indication": {
                "id": 2671,
                "name": "transitional cell carcinoma",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 8466,
                    "pubMedId": 25630452,
                    "title": "Exceptional Response on Addition of Everolimus to Taxane in Urothelial Carcinoma Bearing an NF2 Mutation.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25630452"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 27471,
            "profileName": "ATM V2119fs ATR mut NF2 Y153fs TP53 R280K",
            "profileTreatmentApproaches": [
                
            ]
        },
        {
            "id": 30612,
            "profileName": "NF2 Y153fs",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 88868,
            "transcript": "NM_000268",
            "gDna": "chr22:g.29654667dupA",
            "cDna": "c.458dupA",
            "protein": "p.Y153fs*1",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 88866,
            "transcript": "NM_181832",
            "gDna": "chr22:g.29654667dupA",
            "cDna": "c.458dupA",
            "protein": "p.Y153fs*1",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 88869,
            "transcript": "NM_181825",
            "gDna": "chr22:g.29654667dupA",
            "cDna": "c.458dupA",
            "protein": "p.Y153fs*1",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 88867,
            "transcript": "NM_016418",
            "gDna": "chr22:g.29654667dupA",
            "cDna": "c.458dupA",
            "protein": "p.Y153fs*1",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}